You’ve been reading about longevity supplements for six months. NMN. NR. Urolithin A. Every other article swears it’s the breakthrough you’ve been waiting for, and every third one contradicts the second. None of them tell you what the actual human evidence says—not the mouse studies, not the speculation, the evidence.

Here’s what we know right now. NMN and NR are NAD+ precursors. Urolithin A works on mitochondria. All three have animal studies showing promise. But the human data is thinner, newer, and far less certain than the marketing suggests. If you’re wondering which one has the most credible track record—or whether any of them do—this is the breakdown you’ve been looking for.

We’re going to compare the mechanisms, look at the actual human clinical trial results, and address the five questions people actually ask when they’re trying to decide whether to spend $70 a month on something that might extend healthspan by 0.1% or might do nothing at all.

Understanding NAD+ Precursors: NMN and NR

NAD+ is a molecule that lives inside every cell you have. It’s involved in energy metabolism, DNA repair, and keeping mitochondria functional. Your NAD+ levels decline as you age—by some estimates, they drop by as much as 50% between your 40s and your 60s. That decline is associated with a lot of the things we call aging: slower metabolism, worse muscle endurance, cognitive fog, cardiovascular stiffness.

NMN and NR are both NAD+ precursors, meaning your body converts them into NAD+. The difference is in the pathway. NR converts to NMN first, then to NAD+. NMN skips that first step and converts directly to NAD+. That’s the basis for claims that NMN is “more efficient,” but whether that difference matters in a real human body is still being worked out.

The logic is simple: if NAD+ declines with age, and that decline contributes to aging, then raising NAD+ should slow aging or reverse some of its effects. The logic holds in mice. Whether it holds in humans at the doses people actually take is the open question.

NMN: Evidence in Longevity Research

The animal studies for NMN are compelling. Mice given NMN showed increased NAD+ levels, improved energy metabolism, better insulin sensitivity, and extended lifespans. In one widely cited study, NMN supplementation suppressed age-associated weight gain, improved eye function, and enhanced mitochondrial metabolism. These weren’t marginal effects—they were the kind of results that make researchers start calling something a “breakthrough.”

The human data is newer and more cautious. A 2021 randomized controlled trial gave pre-diabetic women 300 mg of NMN daily for 10 weeks. Results: improved insulin sensitivity and better muscle insulin signaling. Another study in 2022 found that 250 mg of NMN daily for 12 weeks improved arterial stiffness in healthy middle-aged adults and increased NAD+ levels in the blood.

Those are real effects. But they’re also narrow. Improved insulin sensitivity in pre-diabetic women doesn’t mean NMN will extend your lifespan. Reduced arterial stiffness in middle-aged adults doesn’t mean it prevents heart disease. The studies show that NMN can raise NAD+ levels and produce measurable metabolic benefits in humans. They don’t yet show that those benefits translate into longer, healthier lives.

Most human trials have been small—fewer than 50 participants—and short-term, lasting 10 to 12 weeks. The doses range from 250 mg to 300 mg per day. NMN appears well-tolerated at these doses, with few reported side effects. But long-term safety data in humans is still thin. We don’t have 10-year human studies showing sustained benefits or no hidden risks.

NR: Evidence in Longevity Research

NR has a longer track record in human trials than NMN. It consistently raises NAD+ levels in humans, and it’s been shown to be safe for short-term use in multiple studies. Preclinical work in animals demonstrated that NR can counteract age-related NAD+ decline, improve mitochondrial function, reduce inflammation, and extend lifespan in model organisms. Those results mirror NMN’s animal data—robust, reproducible, and promising.

In humans, the results are more mixed. NR has been tested for muscle endurance, cardiometabolic health, and cognitive function. Some studies found modest improvements in muscle endurance. Others found no significant change in muscle strength, insulin sensitivity, or cardiovascular function in healthy adults. The pattern that emerges is this: NR reliably raises NAD+, but the downstream benefits vary depending on the population, the dose, and the outcome measured.

One reason for the inconsistency might be that NAD+ depletion isn’t the only thing driving aging. Raising NAD+ might help people whose aging is limited by NAD+ decline, but for others—whose aging is driven more by inflammation, oxidative stress, or mitochondrial dysfunction—raising NAD+ alone might not be enough.

NR is generally well-tolerated. The most common side effects reported are mild nausea or flushing at higher doses. Like NMN, most human studies have been short-term, and we don’t yet have data on what happens when someone takes NR every day for 20 years.

Urolithin A: Mitochondrial Health and Longevity

Urolithin A is different. It’s not an NAD+ precursor. It’s a metabolite your gut produces when you eat foods rich in ellagitannins—pomegranates, walnuts, berries. But here’s the catch: only 30 to 40% of people naturally produce enough Urolithin A, because production depends on having the right gut bacteria. For most people, eating a pomegranate doesn’t do much.

Urolithin A’s mechanism is mitophagy—the process by which cells clear out damaged mitochondria and replace them with new ones. Mitochondria are the energy factories inside your cells. As you age, they accumulate damage, and your cells get worse at clearing them out. That leads to declining energy, muscle weakness, and slower recovery. Urolithin A activates the cleanup process and promotes mitochondrial biogenesis, the creation of new mitochondria.

Animal studies showed that Urolithin A extended lifespan in worms, increased activity in older mice, and improved muscle fiber organization. In one study, it decreased mitochondrial content in young worms while maintaining maximal respiratory capacity, and increased mitochondrial numbers in older worms—suggesting it optimizes mitochondrial quality, not just quantity.

Human trials have been more definitive than those for NMN or NR. Randomized clinical trials using 500 to 1,000 mg of Urolithin A daily showed improved muscle endurance and better mitochondrial biomarkers, particularly in older adults. A 2025 study suggested that 1,000 mg of Urolithin A could improve immune fitness in healthy adults aged 45 to 70 by increasing naive CD8+ T-cell levels and reducing exhaustion markers. That’s not just a metabolic effect—it’s an immune effect, which opens up a different angle on aging.

Urolithin A’s human data is still limited to relatively small trials, but the effects measured so far have been consistent and biologically meaningful. The challenge is that, unlike NMN or NR, Urolithin A isn’t something your body can easily make from a precursor. You either produce it naturally (if you have the right gut bacteria) or you take it as a supplement.

NMN, NR, and Urolithin A: A Comparative Look

NMN and NR are targeting the same system: NAD+ levels. They’re both precursors, and they both raise NAD+ in humans. The difference is in the conversion pathway, and whether that difference matters in practice is still being debated. NMN skips one step, which theoretically makes it more direct. NR has more published human trials, which theoretically makes it better-studied. But neither has definitive long-term human data showing that raising NAD+ extends lifespan or prevents age-related disease.

Urolithin A is targeting a different system: mitochondrial quality. It’s not about raising NAD+—it’s about clearing out damaged mitochondria and promoting new ones. The human evidence for Urolithin A is narrower but more consistent. The studies show measurable improvements in muscle endurance and mitochondrial biomarkers in older adults. That’s not the same as proving it extends lifespan, but it’s more than what we have for NMN or NR in terms of functional outcomes.

Some researchers suggest that NMN and Urolithin A could be complementary. NMN provides the fuel (NAD+), and Urolithin A optimizes the engines (mitochondria). The logic is appealing, but there’s no large-scale human trial testing that combination yet.

The broader truth is this: all three have exciting preclinical data. All three have some human data showing they’re safe and can produce measurable effects. None of them have the kind of long-term, large-scale human trials that would let us say with confidence, “This will extend your healthspan by X years.” We’re still in the early-evidence phase. The science is real, but the certainty isn’t there yet.

Frequently Asked Questions

What are the main differences in how NMN, NR, and Urolithin A work?

NMN and NR are NAD+ precursors—they raise NAD+ levels, which support cellular energy metabolism, DNA repair, and mitochondrial function. Urolithin A targets mitochondrial quality directly by activating mitophagy, the process that clears out damaged mitochondria and promotes the creation of new ones. They’re working on related but distinct systems.

Which supplement has the most conclusive human evidence for longevity?

None of them have conclusive evidence that they extend human lifespan. Urolithin A has the most consistent human trial data showing functional benefits like improved muscle endurance and mitochondrial biomarkers in older adults. NMN and NR have shown they can raise NAD+ levels in humans, with some evidence of metabolic benefits like improved insulin sensitivity or arterial stiffness, but those effects are narrower and shorter-term.

Can NMN, NR, and Urolithin A be taken together, and are there benefits to doing so?

They target different pathways, so in theory they could be complementary—NMN or NR for NAD+ fuel, Urolithin A for mitochondrial engines. But there’s no large-scale human study testing that combination yet. If you’re considering it, start with one, see how your body responds, and consult a clinician before stacking multiple longevity supplements. Interactions aren’t well-studied.

Are there any known side effects or safety concerns for these supplements?

All three are generally well-tolerated in the doses used in human studies. NMN and NR can cause mild nausea or flushing at higher doses. Urolithin A has been tested at doses up to 1,000 mg daily with no serious adverse effects reported. But long-term safety data—what happens after 10 or 20 years of daily use—is still lacking. If you have a pre-existing condition or take other medications, talk to your doctor before starting any of these.

How can I naturally boost Urolithin A production in my gut?

Eat foods rich in ellagitannins: pomegranates, walnuts, raspberries, strawberries, blackberries. But only 30 to 40% of people have the gut bacteria needed to convert ellagitannins into Urolithin A. If you don’t produce it naturally, eating more pomegranates won’t help. Supplementation is the more reliable route for most people. You can also work on improving your gut microbiome diversity through fiber, fermented foods, and reducing antibiotic use, but there’s no guarantee that will get you to Urolithin A production.

The Bottom Line

The science behind NMN, NR, and Urolithin A is real. The animal studies are compelling. The human data is emerging, and it shows these compounds can produce measurable effects—raised NAD+ levels, improved metabolic markers, better muscle endurance, enhanced mitochondrial function. But we don’t yet have the long-term human trials that would let us say with certainty that any of them will extend your healthspan or prevent age-related decline.

If you’re considering one of these supplements, the question isn’t whether the science is interesting. It is. The question is whether the current evidence justifies the cost and the risk of being an early adopter. For some people, the answer is yes. For others, waiting another five years for more data makes more sense. Either way, don’t mistake promising preclinical research for proven human benefit. The gap between the two is still real.

Continue reading: Read the pillar — Supplements & Nutrition

This article is for informational purposes only and is not financial advice. Consult a qualified professional for personalized guidance.